Skip to main content
. 2016 Sep 10;7(43):69749–69759. doi: 10.18632/oncotarget.11949

Table 1. Clinical characteristic of lymphoepithelioma-like cholangiocarcinoma.

Case Age (year) Sex Tumor site Tumor size (cm) HBV HCV EBER AFP (ng/ml) CA199 (u/ml) Clinical outcome
1 60 M Right lobe 6.0 + + 2.1 1.1 DOD, 27 months follow-up
2 53 M Right lobe 2.4 + 2.7 23.1 DOD, 22 months follow-up
3 39 M Left lobe 2.0 3.0 7.6 AWOD, 54 months follow-up
4 43 F Right lobe 1.2 + 2.3 7.4 AWOD, 51 months follow-up
5 62 M Right lobe 3.2 + 4.7 36.0 AWOD, 37 months follow-up
6 65 F Right lobe 5.0 + 42.4 21.0 AWOD, 37 months follow-up
7 47 F Left lobe 1.9 + 1.9 2.7 AWOD, 35 months follow-up
8 52 M Right lobe 1.9 + 1.3 9.8 AWOD, 19 months follow-up
9 60 M Left lobe 2.6 + 1.5 15.5 AWOD, 12 months follow-up
10 61 M Right lobe 2.4 + 3.8 14.7 AWD, 12 months follow-up Intrahepatic recurrence (10 months)
11 35 M Right lobe 3.1 + + 3.3 13.1 AWOD, 10 months follow-up
12 48 M Right lobe 3.5 + 1.4 3.5 AWOD, 9 months follow-up
13 71 F Right lobe 2.2 + 1.7 4.0 AWOD, 8 months follow-up

AWOD, Alive without disease; AWD, alive with disease; DOD, died of disease.